Is HYPD or IDYA more undervalued in 2026?

CirclFi compares Hyperion DeFi, Inc. (HYPD) and IDEAYA Biosciences, Inc. (IDYA) using 13 institutional-grade valuation models. HYPD has a Quality of Company score of 5.1/10 while IDYA scores 6.4/10.

Which is a better buy — HYPD or IDYA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HYPD and IDYA valuations compare?

HYPD at $3.50 and IDYA at $29.47 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HYPD vs IDYA Valuation Comparison 2026 — Intrinsic Value Analysis

HYPD

Pharmaceutical Preparations

Hyperion DeFi, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$3.50

Last close

Models

11/13

Active

IDYA

Pharmaceutical Preparations

IDEAYA Biosciences, Inc.

Quality

6.4

out of 10

Value Trap

SAFE

Price

$29.47

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	HYPD Fair Value	HYPD Upside	IDYA Fair Value	IDYA Upside
Bayesian DCF	Intrinsic	$1.10	-68.6%	$7.23	-75.5%
Earnings Power Value	Intrinsic	$1.61	-61.4%	$16.44	-46.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HYPD vs IDYA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HYPD vs IDYA — Which Stock Is More Undervalued?

IDYA scores higher with a 6.4/10 quality rating vs HYPD's 5.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Hyperion DeFi, Inc. (HYPD) and IDEAYA Biosciences, Inc. (IDYA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HYPD currently trades at $3.50 with a QOC of 5.1/10, while IDYA trades at $29.47 with a QOC of 6.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).